The association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016.

We observed an ~27% reduction in rates of overtreatment of men with low-risk PCa over the study period. Several patient, disease, and structural characteristics are associated with detection of iPCa at RP and can inform the management of men with low-risk PCa to reduce potential overtreatment.